As of 2024-12-15, the Intrinsic Value of TRYP Therapeutics Inc (TRYP.CN) is
-0.25 CAD. This TRYP.CN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.06 CAD, the upside of TRYP Therapeutics Inc is
-514.28%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-0.25 CAD
Intrinsic Value
TRYP.CN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-0.25 - -0.25 |
-0.25 |
-514.28% |
| P/E |
0.06 - 0.06 |
0.06 |
-0.6% |
| DDM - Stable |
2.20 - 2.55 |
2.37 |
3855.4% |
| DDM - Multi |
2.49 - 2.05 |
2.26 |
3661.3% |
TRYP.CN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
5.79 |
| Beta |
-3.73 |
| Outstanding shares (mil) |
96.42 |
| Enterprise Value (mil) |
8.73 |
| Market risk premium |
5.10% |
| Cost of Equity |
2.33% |
| Cost of Debt |
5.00% |
| WACC |
2.69% |